Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CS MEDICA A/S: CANNASEN® is now a registered brand in Hong Kong and New Zeeland

CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the Company has received certificates of registration for trademark CANNASEN® in Hong Kong and New Zealand. This marks an important step for securing the brand in the Company’s expansion on the global market.CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces today that the trademark offices in New Zealand and Hong Kong have approved CS MEDICA’s trademark CANNASEN®. “One of the things to secure when building a global business is trademarks. CS MEDICA has always been active in filing patents to secure the future for our

IFS reports sharp increase in ARR + 33% YoY supporting a shift in the revenue mix with 71% of Total Revenues YTD now being Recurring

· ARR uplift driven by a rapid increase in the share of Cloud[*] (68% of ACV) and Subscription (78% of ACV) YTD. · Software Revenues YTD representing 76% of Total RevenuesLondon, UK, July  26, 2022 – IFS , the global cloud enterprise software company, today reported its financial results for H1 as of June 30, 2022, with its share of Recurring Revenue reaching 71 percent of Total Revenues and Software Revenues reaching 76 percent of Total Revenues. Growth in H1 2022 came from winning net new customers as well as from the IFS install base who continue to upgrade to

Isofol receives approval of biomarker analysis patent and intention-to-grant patent application for study dose regimen in Europe

GOTHENBURG, Sweden, July 26, 2022 – Isofol Medical AB  (publ) (Nasdaq Stockholm: ISOFOL), today announced the European approval for a patent covering the clinical use of a biomarker analysis to detect cancer patients ability to respond to folate-based therapy cancer treatments and an intention-to-grant patent application for a patent covering the AGENT study dose regimen in Europe.The patent approved covering the clinical use of a biomarker analysis is valid until 2035 and was approved in the US in 2019. The dose regimen patent covering the claim of the use of

Invitation to presentation of Storytel AB’s Q2 Report 2022

On 5 August 2022 at 8.00 AM CET, Storytel AB will publish its Q2 Report for 2022. Storytel AB will hold a presentation of the report on the same day and invites investors, analysts and media to an audiocast with teleconference at 09.30 AM CET. The presentation will be in English and followed by a Q&A with Storytel’s Acting Chief Executive Officer Ingrid Bojner and Interim Chief Financial Officer Susanne Ekblom.The Q2 Report for 2022 will be available here  at 8.00 AM CET on 5 August. Information to participants:

WithSecure™ Detects New Infostealer Malware DUCKTAIL

DUCKTAIL has been targeting marketing and HR professionals through LinkedIn spear phishing campaigns to hijack Facebook business accounts for financial gainsHelsinki, Finland – July 26, 2022: WithSecure™ has discovered an ongoing operation, dubbed "DUCKTAIL", that targets individuals and organizations operating on Facebook's Ads and Business platform. Based upon analysis and gathered data, WithSecure™ has high confidence that the operation is conducted by a Vietnamese threat actor. The chain of evidence suggests that the threat actor's motives are financially driven. DUCKTAIL's

Stora Enso survey finds physical books still outperform e-books in share of hearts and minds, with carbon neutrality a big consideration.

STORA ENSO OYJ PRESS RELEASE 26 July 2022 at 13:00 EESTA new survey commissioned by Stora Enso in March 2022 among 2,400 book readers and listeners in the UK, France, Germany and the US showed that people still overwhelmingly prefer physical books (65%) to e-books (21%) or audiobooks (14%). And consumers are willing to pay a premium for carbon neutral books.    “With the book market strong coming out of the pandemic, our goal with this survey was to gain insights into whether the market would stay that way in a post-pandemic world. And the answer we got was a resounding yes,” says

Invitation to interim report livestream on 2 August 2022

Paradox Interactive will host a livestream on the company’s YouTube channel in connection with the publication of the company’s interim report for January to June for the fiscal year 2022. Fredrik Wester, CEO, and Alexander Bricca, CFO, will present the quarter’s results, and answer questions related to the report and the company’s financial performance.Date: August 2 2022Time: 12:00 PM CESTLink:  https://youtube.com/paradoxinteractiveThe interim report will be published at 08:00 AM CEST on 2 August and will be available at  

P CAPITAL PARTNERS IV B ISSUES NEW DEBENTURES

PRESS RELEASE Stockholm, 26 July 2022 P Capital Partners IV B AB (publ) today announces that on 9 August 2022, the company will increase its contributed capital by EUR 36.9 million through the issuance of 168,792 series A1 and 15,600 series A2 participation loan debentures at a price of EUR 96 each and 19,890 series B participation loan debentures at a price of EUR 960 each and by an equity contribution of EUR 0.14 million. The new debentures will be eligible for coupon payments from the fourth quarter 2022. The newly issued debentures in P Capital Partners IV B amounts to EUR

ChromoGenics wins new orders for ConverLight Static glass

ChromoGenics receives new orders for ConverLight® Static glass of approximately SEK 1.1 million for delivery during 2022.The orders involve ConverLight® Static glass for Humlegården’s Stora Blå property in Solna, Sweden and for one of Vasakronan’s properties in Uppsala, Sweden. The projects, with a total value of approximately 1.1 MSEK, will be delivered during the fall of 2022 in cooperation with Bollan AB. ChromoGenics have completed several projects in cooperation with Bollan AB, a quality conscious installation company of high-tech façade and window glass in the Stockholm region. With

Repurchase of NCC Series B shares in week 29, 2022

During the period July 18 – July 22, 2022, NCC (LEI-code 213800WRGLW3CY4MHW53) repurchased a total of 350 309 own Series B shares (ISIN: SE0000117970) under the framework of the repurchase program that the Board have decided.The repurchases are part of the repurchase program of a maximum of 10 percent of Series B shares for a total of not more than SEK 1.5 bn that NCC announced on April 27, 2022. The repurchase program extends from May 11, 2022 until the 2023 Annual General Meeting and is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the

Glaston’s Half-year financial report 2022 to be published on Thursday, August 4, 2022 at 8.30 a.m.

Glaston Corporation   Press release                  26.7.2022 at 11.30Glaston Corporation will publish its Half-year financial report for the period January 1–June 30, 2022 on Thursday, August 4, 2022 at around 8.30 a.m. Finnish time. The report and presentation will be available as soon as possible after publishing on the Company’s internet pages at www.glaston.net.Glaston’s CEO Anders Dahlblom and CFO Päivi Lindqvist will present the financial result to analysts, investors and media representatives on the publication day at 11.00 (Finnish time) in English. The live webcast can be

S2Medical AB (publ) signs exclusive distribution agreement for the Qatari market

S2Medical AB (publ) has signed an exclusive distribution agreement for the Qatari market with Wesburry Trading. The agreement covers all products that are represented by S2Medical in the region and implies initial orders of about 250 000 SEK as well as commitments to further orders of at least 8 million SEK over the coming 3 years to keep the validity of the agreement. Wesburry Trading is a large distribution company in Qatar that represent many known brands within several categories of medical products. ”Qatar has been one of few countries in the GCC region where our products haven’t

Notice to attend the Annual General Meeting of Lagercrantz Group AB (publ)

The shareholders of Lagercrantz Group AB (publ) (“the Company”) are hereby given notice to attend the Annual General Meeting to be held at 4.00 p.m., on Tuesday, 30 August 2022, at IVA’s Conference Centre, Grev Turegatan 16 in Stockholm.  Information in connection with Covid-19Lagercrantz Group is closely monitoring developments in relation to Covid-19 as well as advice and regulations from public authorities and will publish updated information about the Annual General Meeting on the website if necessary. NOTICE OF PARTICIPATION Shareholders who wish to participate in the

Hexagon Purus ASA: Invitation to presentation of second quarter 2022 results

Hexagon Purus ASA’s second quarter results 2022 will be released on 9 August 2022, 07:00 CET. Morten Holum (CEO) and Dilip Warrier (CFO) will present the results at 08:30 CET and the presentation will be broadcasted live via https://hexagonpurus.kg5.no/. The presentation will be held in English and be virtual. A recording of the presentation will be made available on www.hexagonpurus.com. For more information: Mathias Meidell, Investor Relations Director, Hexagon Purus ASATelephone: +47 909 82 242 | mathias.meidell@hexagonpurus.com Dilip Warrier, CFO, Hexagon Purus ASA

The board of directors exercises authorizations to issue and repurchase C-shares

Truecaller AB today announces that the board of directors exercises authorizations to issue and repurchase C-shares to secure the company’s commitments under share program 2022 (as part of the incentive program LTIP 2022).The annual general meeting of Truecaller AB on 24 May 2022 resolved – for the purpose of ensuring that the company can fulfil its commitments under the share program 2022 resolved by the annual general meeting – to authorize the board of directors to resolve on a directed share issue of redeemable- and convertible class C shares. The annual general meeting also resolved

Kalqyl publish initial take analysis on Scandinavian ChemoTech

A commissioned research analysis was published today by Kalqyl AB and is accessible on their website."ChemoTech has a clear short-term trigger and inflection point based on the fact that the company recently entered the commercial phase. We see this together with several new collaborations and agreements as strong validation for the potential of ChemoTech's technology platform." writes Peter Westberg, Analyst at Kalqyl AB.   The analysis will be disseminated on Kalqyl's Twitter channels and also via Nordnet, Avanza, Di.se, Eikon, Bloomberg and more.   See the full analysis on

Cooper University Health Care in the US selects Sectra’s subscription model for enterprise imaging

Linköping, Sweden – July 26, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will install its enterprise imaging system at Cooper University Health Care in the US. The contract includes modules for radiology and breast imaging as well as the Sectra VNA to store all radiology images, as well as cardiology images, generated throughout the organization. This unified imaging approach will provide caregivers a full patient overview and allow breast radiologists to view all modalities from one system.The contract signed in June 2022,

Mandatory notification of trade

Magdalena Kadziolka, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 25th July 2022, acquired interests in shares of Otello Corporation ASA. The balance of Magdalena Kadziolka and related parties’ holdings after the transaction totals 28,587,165 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

New shares of Nurminen Logistics Plc registered with the trade register

Nurminen Logistics Plc      Stock Exchange Release July, 26, 2022, at 9.30 am A total of 133,078 new shares (the “New Shares”) issued in Nurminen Logistics Plc’s (the “Company”) share issue to the Company itself without consideration has been registered with the Trade Register on July 26, 2022. Following the registration of the New Shares, the total number of the Company’s shares is 78,101,654 shares. The new 133,078 shares are for the remuneration of the members of the Board of Directors in accordance with the decision of the Annual General Meeting on April 11, 2022. After the transfer,

Latest data on lecanemab to be presented at Alzheimer’s Association International Conference (AAIC)

Stockholm, July 26, 2022 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present new data for lecanemab (BAN2401), an investigational anti-amyloid beta (Aβ) protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and mild AD (collectively known as early AD) with confirmed presence of amyloid pathology in the brain, at the Alzheimer’s Association International Conference (AAIC) to be held in San Diego, California and virtually from July 31 to August 4, 2022. Eisai will present lecanemab data and research in one oral and

Elkem ASA – Update on the merger with Salten Energigjenvinning AS

Oslo, 26 July 2022 Reference is made to Elkem ASA's ("Elkem") announcement on 18 July 2022 regarding the merger of Salten Energigjenvinning AS into Elkem.  Elkem has today sent the enclosed information letter on the merger to its shareholders. The merger plan and the companies’ annual accounts, annual reports and auditor’s report for the last tree financial years are available at Elkem’s webpage: http:///www.elkem.com/no/investor/ . This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. For further information,

Transcom Holding AB (publ) announces changes in the Board of Directors

Transcom Holding AB today announced that Board Member Lisa Stoner has resigned from the company’s Board of Directors, effective July 25, 2022, in order to focus on her new role as VP of Product and Service Operations at Meta. “Lisa has been a really valued member of the Board. On behalf of the Board and Transcom’s leadership team, I would like to thank Lisa for her dedicated service. I also would like to congratulate Lisa on this new exciting role, and look forward to following her continued journey”, says Fredrik Cappelen, Chairman of the Board. “I would like to thank Fredrik, the

CONCENTRIC INTERIM REPORT JANUARY – JUNE 2022

SECOND QUARTER 2022 · Net sales: MSEK 1,021 (473) – reported sales were up +116% year-on-year. After adjusting for the impact of currency +13% and EMP +78%, sales in constant currency year-on-year were up +25%. · Operating income: MSEK 164 (107), generating an operating margin of 16.1% (22.7). · Net income for the period: MSEK 134 (85); basic EPS of SEK 3.53 (2.25). · Cash flow from operating activities: MSEK 76 (76); cash generation has been affected by increases in working capital to support increased sales. FIRST SIX MONTHS 2022 · Net sales: MSEK 1,955 (905) –

Eltel Group: Half-year report January–June 2022

April–June 2022 · Net sales EUR 208.6 million (210.4). Total growth -0.8% and organic growth1) in segments -2.4% · Operative EBITA2) EUR 0.5 million (4.4) and operative EBITA margin 0.2% (2.1) · Operative EBITA2) in segments EUR 4.4 million (6.8) and operative EBITA margin in segments 2.4% (3.6) · Operating result (EBIT) EUR 0.4 million (4.3) and EBIT margin 0.2% (2.0) · Net result EUR -2.6 million (1.6) · Earnings per share EUR -0.02 (0.01), basic and diluted · Cash flow from operating activities EUR 8.8 million (13.2) January–June 2022 · Net sales EUR 392.6

There are no items matching the current filter
There are no more items matching the current filter
Back to top